These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 9333810

  • 1. [Use of immunochemical studies to predict the course of fibrous cavernous tuberculosis of lung and postoperative complications in patients on chemo and laser therapy].
    Sergeeva LV, Dobkin VG, Baenskií AV, Kulikovskaia NV, Litvinov VI.
    Probl Tuberk; 1997; (4):23-6. PubMed ID: 9333810
    [Abstract] [Full Text] [Related]

  • 2. [Laser and chemotherapy and the immune status of patients with fibrous-cavernous tuberculosis].
    Sergeeva LV, Dobkin VG, Markov AN.
    Probl Tuberk; 1996; (1):22-4. PubMed ID: 8907479
    [Abstract] [Full Text] [Related]

  • 3. [Antituberculosis antibodies in patients with tuberculosis during chemotherapy].
    Stakhanov VA, Vasil'ev NA, Levi DT, Rukhamina ML.
    Probl Tuberk; 2001; (5):48-50. PubMed ID: 11588965
    [Abstract] [Full Text] [Related]

  • 4. [Immunological bases of tuberculin therapy in combined treatment of patients with pulmonary tuberculosis].
    Krylov VA, Gergert VIa, Korotkova ED, Pechaev MG, Kuz'mina NV, Baranova NI.
    Probl Tuberk; 1994; (5):21-3. PubMed ID: 7870717
    [Abstract] [Full Text] [Related]

  • 5. [Effectiveness of artificial pneumothorax in the treatment of patients with pulmonary tuberculosis with multiple drug-resistant Mycobacteria].
    Chukanov VI, Mishin VIu, Sigaev AT, Vasil'eva IA, Osadchaia OA, Perfil'ev AV, Naumova AN, Bagdasarian TR.
    Probl Tuberk Bolezn Legk; 2004; (8):22-4. PubMed ID: 15478553
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Lasers in combined modality treatment of patients with pulmonary tuberculosis].
    Dobkin VG, Bagirov MA, Bondarev GB, Sadovnikova SS.
    Probl Tuberk; 1996; (6):54-7. PubMed ID: 9019773
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The course of a process and the efficiency of treatment of pulmonary tuberculosis patients excreting Mycobacterium tuberculosis with extensive drug resistance to antituberculous drugs].
    Mishin VIu, Komissarova OG, Chukanov VI, Kononets AS.
    Probl Tuberk Bolezn Legk; 2009; (2):50-2. PubMed ID: 19382643
    [Abstract] [Full Text] [Related]

  • 14. [Diagnosis, clinical picture and treatment policy in acute progressive forms of pulmonary tuberculosis under present-day epidemiological conditions].
    Khomenko AG, Mishin VIu, Chukanov VI, Korneev AA, Voronina GA, Vasil'eva IA.
    Probl Tuberk; 1999; (1):22-7. PubMed ID: 10199178
    [Abstract] [Full Text] [Related]

  • 15. [Specific antitubercular immunity in patients with tuberculosis and other pulmonary abnormality: diagnostic value of its study].
    Adambekov DA, Kurmanov RA, Baenskií AV, Litvinov VI.
    Probl Tuberk; 1997; (3):20-3. PubMed ID: 9265163
    [Abstract] [Full Text] [Related]

  • 16. Prediction of delayed treatment response in pulmonary tuberculosis: use of time to positivity values of Bactec cultures.
    Carroll NM, Uys P, Hesseling A, Lawrence K, Pheiffer C, Salker F, Duncan K, Beyers N, van Helden PD.
    Tuberculosis (Edinb); 2008 Nov; 88(6):624-30. PubMed ID: 18456556
    [Abstract] [Full Text] [Related]

  • 17. Serological markers of pulmonary tuberculosis and of response to anti-tuberculosis treatment in a patient population in Guinea.
    Azzurri A, Kanaujia GV, Sow OY, Bah B, Diallo A, Del Prete G, Gennaro ML.
    Int J Immunopathol Pharmacol; 2006 Nov; 19(1):199-208. PubMed ID: 16569358
    [Abstract] [Full Text] [Related]

  • 18. Role of gallium arsenide laser irradiation at 890 nm as an adjunctive to anti-tuberculosis drugs in the treatment of pulmonary tuberculosis.
    Puri MM, Arora VK.
    Indian J Chest Dis Allied Sci; 2003 Nov; 45(1):19-23. PubMed ID: 12683708
    [Abstract] [Full Text] [Related]

  • 19. [Several possibilities of organizing multimodal treatment of patients with pulmonary tuberculosis].
    Savula MM, Kravchenko NS.
    Probl Tuberk; 2001 Nov; (8):26-8. PubMed ID: 11767385
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.